Us Nuclear Financials

UCLE

Source SEC Filings (10-K/10-Q) Updated Sep 30, 2025 Currency USD FYE December

This page shows Us Nuclear (UCLE) financial statements, including the income statement, balance sheet, cash flow statement, and key financial ratios. View 14 years of annual fundamentals and quarterly data, with year-over-year growth rates and compound annual growth rates (CAGR). All figures are derived from SEC filings (10-K and 10-Q reports).

Financial Health Signals

Piotroski F-Score Neutral

5/9

Us Nuclear passes 5 of 9 financial strength tests. 2 of 4 profitability signals pass, 1 of 3 leverage/liquidity signals pass, both operating efficiency signals pass.

Earnings Quality Low Quality

0.29x

For every $1 of reported earnings, Us Nuclear generates $0.29 in operating cash flow (-$509K OCF vs -$1.7M net income). This low ratio suggests earnings are primarily driven by accounting accruals rather than cash generation, which may not be sustainable.

Interest Coverage At Risk

-6.8x

Us Nuclear earns $-6.8 in operating income for every $1 of interest expense (-$1.5M vs $225K). This narrow margin raises concern about the company's ability to service its debt if operating income declines.

Key Financial Metrics

Export CSV

Revenue

$2.2M

YoY-1.8%

5Y CAGR-9.2%

10Y CAGR+3.0%

Us Nuclear generated $2.2M in revenue in fiscal year 2024. This represents a decrease of 1.8% from the prior year.

EBITDA

-$1.5M

YoY+6.4%

Us Nuclear's EBITDA was -$1.5M in fiscal year 2024, measuring earnings before interest, taxes, depreciation, and amortization. This represents an increase of 6.4% from the prior year.

Free Cash Flow

N/A

Net Income

-$1.7M

YoY+49.3%

Us Nuclear reported -$1.7M in net income in fiscal year 2024. This represents an increase of 49.3% from the prior year.

EPS (Diluted)

$-0.04

YoY+60.0%

Us Nuclear earned $-0.04 per diluted share (EPS) in fiscal year 2024. This represents an increase of 60.0% from the prior year.

Cash & Debt

$131K

YoY-14.4%

5Y CAGR-34.5%

10Y CAGR-0.7%

Us Nuclear held $131K in cash against $1.5M in long-term debt as of fiscal year 2024.

Dividends Per Share

N/A

Shares Outstanding

51M

YoY+32.4%

5Y CAGR+21.0%

10Y CAGR+14.5%

Us Nuclear had 51M shares outstanding in fiscal year 2024. This represents an increase of 32.4% from the prior year.

Gross Margin

46.4%

YoY+4.9pp

5Y CAGR-8.3pp

10Y CAGR+1.6pp

Us Nuclear's gross margin was 46.4% in fiscal year 2024, indicating the percentage of revenue retained after direct costs. This is up 4.9 percentage points from the prior year.

Operating Margin

-70.1%

YoY+3.5pp

5Y CAGR-0.6pp

10Y CAGR-51.5pp

Us Nuclear's operating margin was -70.1% in fiscal year 2024, reflecting core business profitability. This is up 3.5 percentage points from the prior year.

Net Margin

-79.4%

YoY+74.5pp

5Y CAGR+9.9pp

10Y CAGR-59.8pp

Us Nuclear's net profit margin was -79.4% in fiscal year 2024, showing the share of revenue converted to profit. This is up 74.5 percentage points from the prior year.

Return on Equity

N/A

R&D Spending

N/A

Share Buybacks

N/A

Capital Expenditures

N/A

UCLE Income Statement

Metric	FY24	FY23	FY22	FY21	FY20	FY19
Revenue	$2.2M-1.8%	$2.2M+6.7%	$2.1M-2.2%	$2.1M+21.9%	$1.8M-50.5%	$3.5M
Cost of Revenue	$1.2M-10.1%	$1.3M+0.3%	$1.3M+71.3%	$761K-40.5%	$1.3M-20.4%	$1.6M
Gross Profit	$1.0M+9.9%	$924K+17.3%	$788K-42.8%	$1.4M+190.1%	$475K-75.5%	$1.9M
R&D Expenses	N/A	N/A	N/A	N/A	N/A	N/A
SG&A Expenses	$1.7M+20.7%	$1.4M+66.0%	$830K+25.2%	$663K+131.2%	$287K-51.5%	$591K
Operating Income	-$1.5M+6.5%	-$1.6M-9.7%	-$1.5M-9.8%	-$1.4M+34.6%	-$2.1M+15.3%	-$2.5M
Interest Expense	$225K-26.6%	$307K+380.6%	$64K+481.0%	$11K-76.0%	$46K-26.9%	$63K
Income Tax	N/A	N/A	N/A	N/A	N/A	N/A
Net Income	-$1.7M+49.3%	-$3.4M-68.1%	-$2.0M-8.9%	-$1.9M+47.0%	-$3.5M-11.9%	-$3.2M
EPS (Diluted)	$-0.04+60.0%	$-0.10-42.9%	$-0.070.0%	$-0.07	N/A	N/A

Metric	Q3'25	Q2'25	Q1'25	Q3'24	Q2'24	Q1'24	Q4'23	Q3'23
Revenue	$595K+33.2%	$447K-6.2%	$477K+6.1%	$449K-10.6%	$503K-19.9%	$628K-2.4%	$643K+8.4%	$594K
Cost of Revenue	$296K+49.8%	$198K+54.7%	$128K-75.3%	$518K+112.3%	$244K-10.9%	$274K-58.2%	$655K+412.7%	$128K
Gross Profit	$299K+20.0%	$249K-28.5%	$349K+604.7%	-$69K-126.7%	$258K-26.9%	$354K+3120.8%	-$12K-102.5%	$466K
R&D Expenses	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
SG&A Expenses	$558K+37.5%	$405K-53.5%	$873K+107519.9%	$811-99.9%	$622K+24.8%	$498K+200.1%	-$498K-192.3%	$539K
Operating Income	-$258K-65.5%	-$156K+70.2%	-$524K+45.3%	-$958K-163.9%	-$363K-151.5%	-$144K+79.4%	-$702K-854.4%	-$74K
Interest Expense	$69K+150.3%	$28K-23.9%	$36K-33.2%	$54K-41.0%	$92K+147.7%	$37K-84.3%	$237K+750.9%	$28K
Income Tax	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Net Income	$147K+170.9%	-$208K+62.9%	-$560K+44.6%	-$1.0M-122.1%	-$455K-181.2%	-$162K+85.8%	-$1.1M-49.7%	-$760K
EPS (Diluted)	$0.00+100.0%	$-0.010.0%	$-0.01+66.7%	$-0.03-200.0%	$-0.01	$0.00+100.0%	$-0.04-100.0%	$-0.02

UCLE Balance Sheet

Metric	FY24	FY23	FY22	FY21	FY20	FY19
Total Assets	$2.6M-7.4%	$2.9M-8.1%	$3.1M+9.0%	$2.9M+16.1%	$2.5M-30.7%	$3.5M
Current Assets	$2.1M-9.1%	$2.3M-9.1%	$2.5M+11.6%	$2.2M+24.5%	$1.8M-34.4%	$2.7M
Cash & Equivalents	$131K-14.4%	$153K+21.2%	$126K-48.8%	$246K+8.4%	$227K-79.1%	$1.1M
Inventory	$1.5M-12.8%	$1.8M-13.0%	$2.0M+13.0%	$1.8M+36.0%	$1.3M+20.0%	$1.1M
Accounts Receivable	$351K+2.7%	$342K+3.7%	$330K+101.7%	$164K-35.9%	$255K-54.5%	$560K
Goodwill	$570K0.0%	$570K0.0%	$570K0.0%	$570K0.0%	$570K0.0%	$570K
Total Liabilities	$3.5M-27.6%	$4.8M+40.0%	$3.5M+43.5%	$2.4M+49.9%	$1.6M-12.7%	$1.8M
Current Liabilities	$2.7M-44.3%	$4.8M+40.0%	$3.5M+43.5%	$2.4M+60.6%	$1.5M+21.0%	$1.2M
Long-Term Debt	$1.5M+165.1%	$570K	N/A	N/A	N/A	$26K
Total Equity	-$856K+56.8%	-$2.0M-469.2%	-$348K-178.9%	$441K-47.9%	$847K-50.2%	$1.7M
Retained Earnings	-$19.7M-6.0%	-$18.6M-22.7%	-$15.1M-15.8%	-$13.1M-17.3%	-$11.1M-46.5%	-$7.6M

Metric	Q3'25	Q2'25	Q1'25	Q3'24	Q2'24	Q1'24	Q4'23	Q3'23
Total Assets	$2.5M+1.3%	$2.5M+0.3%	$2.5M-5.6%	$2.6M-6.9%	$2.8M-2.2%	$2.9M+1.8%	$2.9M-7.9%	$3.1M
Current Assets	$2.0M+1.7%	$1.9M+0.4%	$1.9M-7.2%	$2.1M-8.7%	$2.3M-2.7%	$2.3M+2.3%	$2.3M-9.2%	$2.5M
Cash & Equivalents	$76K+64.0%	$46K-32.4%	$68K-47.7%	$131K-5.1%	$138K+4.3%	$132K-13.5%	$153K-17.3%	$185K
Inventory	$1.7M-5.5%	$1.8M+3.1%	$1.8M+13.9%	$1.5M-15.1%	$1.8M+1.4%	$1.8M+1.3%	$1.8M-14.6%	$2.1M
Accounts Receivable	$130K+237.2%	$39K-36.8%	$61K-82.6%	$351K+25.5%	$280K-28.1%	$389K+13.7%	$342K+41.2%	$242K
Goodwill	$570K0.0%	$570K0.0%	$570K0.0%	$570K0.0%	$570K0.0%	$570K0.0%	$570K0.0%	$570K
Total Liabilities	$2.4M-26.6%	$3.3M+2.4%	$3.2M-9.2%	$3.5M-32.1%	$5.2M+3.6%	$5.0M+2.9%	$4.8M+10.7%	$4.4M
Current Liabilities	$2.2M-8.8%	$2.5M+3.2%	$2.4M-12.0%	$2.7M-47.7%	$5.2M+3.6%	$5.0M+2.9%	$4.8M+10.7%	$4.4M
Long-Term Debt	$347K-68.2%	$1.1M-8.5%	$1.2M-21.2%	$1.5M+127.6%	$664K+0.6%	$660K+15.7%	$570K	N/A
Total Equity	$146K+119.5%	-$751K-10.0%	-$683K+20.3%	-$856K+63.0%	-$2.3M-11.7%	-$2.1M-4.5%	-$2.0M-56.2%	-$1.3M
Retained Earnings	-$20.5M+0.5%	-$20.6M-1.2%	-$20.3M-3.2%	-$19.7M-6.5%	-$18.5M-2.5%	-$18.0M+2.9%	-$18.6M-6.5%	-$17.4M

UCLE Cash Flow Statement

Metric	FY24	FY23	FY22	FY21	FY20	FY19
Operating Cash Flow	-$509K-93.2%	-$263K+80.1%	-$1.3M-200.2%	-$441K+28.2%	-$614K-370.2%	-$131K
Capital Expenditures	N/A	$858	N/A	$6K	N/A	$4K
Free Cash Flow	N/A	-$264K	N/A	-$447K	N/A	-$134K
Investing Cash Flow	-$31K-25.3%	-$25K	N/A	-$21K+90.9%	-$235K+53.3%	-$504K
Financing Cash Flow	$518K+64.5%	$315K-73.9%	$1.2M+150.0%	$481K+4396.3%	-$11K-101.5%	$753K
Dividends Paid	$46K	N/A	N/A	N/A	N/A	N/A
Share Buybacks	N/A	N/A	N/A	N/A	N/A	N/A

Metric	Q3'25	Q2'25	Q1'25	Q3'24	Q2'24	Q1'24	Q4'23	Q3'23
Operating Cash Flow	$150K+197.7%	-$154K-66.1%	-$92K-10.7%	-$84K+16.8%	-$100K-13.4%	-$89K+45.0%	-$161K-283.5%	$88K
Capital Expenditures	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Free Cash Flow	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Investing Cash Flow	N/A	N/A	N/A	-$9K+35.0%	-$14K-257.7%	-$4K-5.1%	-$4K-200.6%	-$1K
Financing Cash Flow	-$121K-191.7%	$131K+336.1%	$30K-84.3%	$192K+59.5%	$120K+67.3%	$72K-46.0%	$133K+5640.1%	$2K
Dividends Paid	-$96K-351.7%	$38K-56.3%	$87K	N/A	N/A	N/A	N/A	N/A
Share Buybacks	$0	N/A	N/A	N/A	N/A	N/A	N/A	N/A

UCLE Financial Ratios

Metric	FY24	FY23	FY22	FY21	FY20	FY19
Gross Margin	46.4%+4.9pp	41.4%+3.7pp	37.7%-26.7pp	64.4%+37.3pp	27.1%-27.6pp	54.6%
Operating Margin	-70.1%+3.5pp	-73.6%-2.0pp	-71.5%-7.8pp	-63.7%+55.2pp	-118.9%-49.4pp	-69.5%
Net Margin	-79.4%+74.5pp	-153.9%-56.2pp	-97.7%-9.9pp	-87.8%+114.0pp	-201.8%-112.5pp	-89.3%
Return on Equity	N/A	N/A	N/A	N/A	N/A	N/A
Return on Assets	-65.7%+54.4pp	-120.2%-54.5pp	-65.7%+0.1pp	-65.8%+78.3pp	-144.1%-54.9pp	-89.3%
Current Ratio	0.77+0.3	0.47-0.3	0.73-0.2	0.93-0.3	1.20-1.0	2.22
Debt-to-Equity	-1.77-1.5	-0.29+9.6	-9.93-15.4	5.46+3.6	1.90+1.9	0.02
FCF Margin	N/A	-11.8%	N/A	-20.9%	N/A	-3.8%

Metric	Q3'25	Q2'25	Q1'25	Q3'24	Q2'24	Q1'24	Q4'23	Q3'23
Gross Margin	50.2%-5.5pp	55.8%-17.4pp	73.2%+88.6pp	-15.4%-66.8pp	51.4%-4.9pp	56.4%+58.2pp	-1.8%-80.3pp	78.5%
Operating Margin	-43.4%-8.5pp	-34.9%+75.0pp	-109.9%+103.4pp	-213.3%-141.1pp	-72.3%-49.3pp	-23.0%+86.2pp	-109.2%-96.8pp	-12.4%
Net Margin	24.8%+71.2pp	-46.5%+71.0pp	-117.5%+107.7pp	-225.2%-134.6pp	-90.6%-64.8pp	-25.8%+151.1pp	-176.9%-48.8pp	-128.1%
Return on Equity	100.7%	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Return on Assets	5.8%+14.1pp	-8.3%+14.1pp	-22.4%+15.8pp	-38.2%-22.2pp	-16.0%-10.4pp	-5.6%+34.3pp	-39.8%-15.3pp	-24.5%
Current Ratio	0.88+0.1	0.79-0.0	0.81+0.0	0.77+0.3	0.44-0.0	0.470.0	0.47-0.1	0.57
Debt-to-Equity	2.37+3.8	-1.45+0.3	-1.74+0.0	-1.77-1.5	-0.29+0.0	-0.32-0.0	-0.29+3.2	-3.44
FCF Margin	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A

Note: Shareholder equity is negative (-$856K), which causes debt-to-equity and return on equity ratios to appear negative or not meaningful. This can occur from accumulated losses or large share buyback programs.

Note: The current ratio is below 1.0 (0.77), indicating current liabilities exceed current assets, which may suggest potential short-term liquidity concerns.

Similar Companies

Track Group Inc TRCK

$3.2M

SATIVUS TECH CORP SATT

$674K

Scientific Ind SCND

$8.1M

Darkpulse DPLS

$4.7M

Lifeloc Technologies Inc LCTC

$8.7M

Frequently Asked Questions

What is Us Nuclear's annual revenue?

Us Nuclear (UCLE) reported $2.2M in total revenue for fiscal year 2024. This represents a -1.8% change compared to the previous fiscal year. Revenue measures the total income earned from the company's primary business operations before any expenses are deducted.

How fast is Us Nuclear's revenue growing?

Us Nuclear (UCLE) revenue declined by 1.8% year-over-year, from $2.2M to $2.2M in fiscal year 2024.

Is Us Nuclear profitable?

No, Us Nuclear (UCLE) reported a net income of -$1.7M in fiscal year 2024, with a net profit margin of -79.4%.

What is Us Nuclear's earnings per share (EPS)?

Us Nuclear (UCLE) reported diluted earnings per share of $-0.04 for fiscal year 2024. This represents a 60.0% change compared to the previous fiscal year. EPS represents the portion of a company's net income allocated to each outstanding share of common stock and is widely used to evaluate profitability on a per-share basis.

What is Us Nuclear's EBITDA?

Us Nuclear (UCLE) had EBITDA of -$1.5M in fiscal year 2024, measuring earnings before interest, taxes, depreciation, and amortization.

How much debt does Us Nuclear have?

As of fiscal year 2024, Us Nuclear (UCLE) had $131K in cash and equivalents against $1.5M in long-term debt.

What is Us Nuclear's gross margin?

Us Nuclear (UCLE) had a gross margin of 46.4% in fiscal year 2024, indicating the percentage of revenue retained after direct costs of goods sold.

What is Us Nuclear's operating margin?

Us Nuclear (UCLE) had an operating margin of -70.1% in fiscal year 2024, reflecting the profitability of core business operations before interest and taxes.

What is Us Nuclear's net profit margin?

Us Nuclear (UCLE) had a net profit margin of -79.4% in fiscal year 2024, representing the share of revenue converted into profit after all expenses.

What is Us Nuclear's operating cash flow?

Us Nuclear (UCLE) generated -$509K in operating cash flow during fiscal year 2024, representing cash generated from core business activities.

What are Us Nuclear's total assets?

Us Nuclear (UCLE) had $2.6M in total assets as of fiscal year 2024, including both current and long-term assets.

How many shares does Us Nuclear have outstanding?

Us Nuclear (UCLE) had 51M shares outstanding as of fiscal year 2024.

What is Us Nuclear's current ratio?

Us Nuclear (UCLE) had a current ratio of 0.77 as of fiscal year 2024, which is below 1.0, which may suggest potential liquidity concerns.

What is Us Nuclear's debt-to-equity ratio?

Us Nuclear (UCLE) had a debt-to-equity ratio of -1.77 as of fiscal year 2024, measuring the company's financial leverage by comparing total debt to shareholder equity.

What is Us Nuclear's return on assets (ROA)?

Us Nuclear (UCLE) had a return on assets of -65.7% for fiscal year 2024, measuring how efficiently the company uses its assets to generate profit.

What is Us Nuclear's cash runway?

Based on fiscal year 2024 data, Us Nuclear (UCLE) had $131K in cash against an annual operating cash burn of $509K. This gives an estimated cash runway of approximately 3 months at the current burn rate. Cash runway measures how long a company can continue operating before running out of cash, assuming no additional funding.

Why is Us Nuclear's debt-to-equity ratio negative or unusual?

Us Nuclear (UCLE) has negative shareholder equity of -$856K as of fiscal year 2024, which causes the debt-to-equity ratio to appear negative or not meaningful. This can occur when accumulated losses exceed invested capital, or after large share buyback programs. Other solvency metrics like the current ratio or interest coverage may be more informative.

What is Us Nuclear's Piotroski F-Score?

Us Nuclear (UCLE) has a Piotroski F-Score of 5 out of 9, indicating neutral financial health. The F-Score evaluates nine binary signals across profitability (positive ROA, positive cash flow, improving ROA, earnings quality), leverage (decreasing debt, improving liquidity, no share dilution), and operating efficiency (improving gross margin, improving asset turnover). Scores of 7–9 indicate strong and improving fundamentals. Learn more in our complete guide to financial health indicators.

Are Us Nuclear's earnings high quality?

Us Nuclear (UCLE) has an earnings quality ratio of 0.29x, considered low quality (accrual-driven). This ratio compares operating cash flow to net income. A ratio above 1.0x means the company generates more cash than its reported earnings, indicating sustainable, cash-backed profits. Ratios below 1.0x suggest earnings rely on accounting accruals rather than actual cash generation. Learn more in our complete guide to financial health indicators.

Can Us Nuclear cover its interest payments?

Us Nuclear (UCLE) has an interest coverage ratio of -6.8x, meaning it can struggle to cover its interest obligations. This ratio divides operating income by interest expense. Ratios above 5x indicate strong debt-servicing ability, while ratios below 2x suggest the company may face difficulty meeting interest payments if earnings decline. Learn more in our complete guide to financial health indicators.